Vom kranken Herz-Gesetz – oder wie mit Studien Politik gemacht wird
Arzte Zeitung ,
Lobbyismus sei etwas Gutes, sagt man. Weil Politiker gar nicht alles verstehen können, wozu sie Gesetze machen sollen.
Differences in dyslipidemia guidelines underscore complexity of CVD prevention
Healio.com,
The use of lipid-lowering therapy has been a hallmark of CV risk reduction for several decades.
Alirocumab reduces risk of initial and repeat CV events after ACS
Cardiovascular Business,
“To analyze recurrent events in a clinical trial is atypical but, in the present case, very informative,” Jacques Genest, MD…
Total CV Event Reduction More Effectively Assesses Alirocumab Efficacy After ACS
Medical Health News,
Share this content: Total cardiovascular event reduction may represent a more comprehensive metric to assess alirocumab…